Towards Innovative Design and Application of Recombinant Eimeria as a Vaccine Vector

Infect Immun. 2020 Apr 20;88(5):e00861-19. doi: 10.1128/IAI.00861-19. Print 2020 Apr 20.

Abstract

Efficient delivery of antigenic cargo to trigger protective immune responses is critical to the success of vaccination. Genetically engineered microorganisms, including virus, bacteria, and protozoa, can be modified to carry and deliver heterologous antigens to the host immune system. The biological vectors can induce a broad range of immune responses and enhance heterologous antigen-specific immunological outcomes. The protozoan genus Eimeria is widespread in domestic animals, causing serious coccidiosis. Eimeria parasites with strong immunogenicity are potent coccidiosis vaccine candidates and offer a valuable model of live vaccines against infectious diseases in animals. Eimeria parasites can also function as a vaccine vector. Herein, we review recent advances in design and application of recombinant Eimeria as a vaccine vector, which has been a topic of ongoing research in our laboratory. By recapitulating the establishment of an Eimeria transfection platform and its application, it will help lay the foundation for the future development of effective parasite-based vaccine delivery vectors and beyond.

Keywords: Eimeria; immune response; immune responses; protection; transient and stable transfection; vaccine vector.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antigens, Protozoan / genetics
  • Coccidiosis / immunology
  • Eimeria / genetics*
  • Humans
  • Microorganisms, Genetically-Modified / genetics
  • Protozoan Vaccines / genetics*
  • Vaccination / methods
  • Vaccines, Attenuated / genetics
  • Vaccines, Synthetic / genetics*

Substances

  • Antigens, Protozoan
  • Protozoan Vaccines
  • Vaccines, Attenuated
  • Vaccines, Synthetic